Logo image of BAKKA.OL

BAKKAFROST P/F (BAKKA.OL) Stock Fundamental Analysis

Europe - Euronext Oslo - OSL:BAKKA - FO0000000179 - Common Stock

459.8 NOK
+6.2 (+1.37%)
Last: 11/26/2025, 12:42:19 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to BAKKA. BAKKA was compared to 59 industry peers in the Food Products industry. Both the profitability and the financial health of BAKKA get a neutral evaluation. Nothing too spectacular is happening here. BAKKA is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

BAKKA had positive earnings in the past year.
In the past year BAKKA had a positive cash flow from operations.
Each year in the past 5 years BAKKA has been profitable.
In the past 5 years BAKKA always reported a positive cash flow from operatings.
BAKKA.OL Yearly Net Income VS EBIT VS OCF VS FCFBAKKA.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B -2B -3B

1.2 Ratios

The Return On Assets of BAKKA (1.30%) is worse than 66.10% of its industry peers.
BAKKA's Return On Equity of 2.19% is on the low side compared to the rest of the industry. BAKKA is outperformed by 71.19% of its industry peers.
BAKKA's Return On Invested Capital of 4.10% is in line compared to the rest of the industry. BAKKA outperforms 49.15% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BAKKA is in line with the industry average of 7.13%.
Industry RankSector Rank
ROA 1.3%
ROE 2.19%
ROIC 4.1%
ROA(3y)5.68%
ROA(5y)5.43%
ROE(3y)9.21%
ROE(5y)8.65%
ROIC(3y)6.71%
ROIC(5y)5.53%
BAKKA.OL Yearly ROA, ROE, ROICBAKKA.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

BAKKA has a Profit Margin (3.49%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of BAKKA has declined.
BAKKA has a Operating Margin of 13.65%. This is amongst the best in the industry. BAKKA outperforms 81.36% of its industry peers.
BAKKA's Operating Margin has declined in the last couple of years.
BAKKA's Gross Margin of 71.02% is amongst the best of the industry. BAKKA outperforms 96.61% of its industry peers.
BAKKA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 13.65%
PM (TTM) 3.49%
GM 71.02%
OM growth 3Y13.95%
OM growth 5Y-7.81%
PM growth 3Y-19.8%
PM growth 5Y-13%
GM growth 3Y1.78%
GM growth 5Y0.18%
BAKKA.OL Yearly Profit, Operating, Gross MarginsBAKKA.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BAKKA is destroying value.
BAKKA has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, BAKKA has more shares outstanding
The debt/assets ratio for BAKKA has been reduced compared to a year ago.
BAKKA.OL Yearly Shares OutstandingBAKKA.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
BAKKA.OL Yearly Total Debt VS Total AssetsBAKKA.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

BAKKA has an Altman-Z score of 2.74. This is not the best score and indicates that BAKKA is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of BAKKA (2.74) is better than 69.49% of its industry peers.
A Debt/Equity ratio of 0.47 indicates that BAKKA is not too dependend on debt financing.
BAKKA has a Debt to Equity ratio (0.47) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF N/A
Altman-Z 2.74
ROIC/WACC0.51
WACC8.07%
BAKKA.OL Yearly LT Debt VS Equity VS FCFBAKKA.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

BAKKA has a Current Ratio of 12.90. This indicates that BAKKA is financially healthy and has no problem in meeting its short term obligations.
BAKKA has a Current ratio of 12.90. This is amongst the best in the industry. BAKKA outperforms 98.31% of its industry peers.
BAKKA has a Quick Ratio of 2.27. This indicates that BAKKA is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of BAKKA (2.27) is better than 86.44% of its industry peers.
Industry RankSector Rank
Current Ratio 12.9
Quick Ratio 2.27
BAKKA.OL Yearly Current Assets VS Current LiabilitesBAKKA.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

5

3. Growth

3.1 Past

BAKKA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -50.91%.
The Earnings Per Share has been decreasing by -1.36% on average over the past years.
BAKKA shows a small growth in Revenue. In the last year, the Revenue has grown by 2.70%.
BAKKA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.21% yearly.
EPS 1Y (TTM)-50.91%
EPS 3Y21.53%
EPS 5Y-1.36%
EPS Q2Q%-100%
Revenue 1Y (TTM)2.7%
Revenue growth 3Y9.71%
Revenue growth 5Y10.21%
Sales Q2Q%-2.9%

3.2 Future

Based on estimates for the next years, BAKKA will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.19% on average per year.
Based on estimates for the next years, BAKKA will show a quite strong growth in Revenue. The Revenue will grow by 8.18% on average per year.
EPS Next Y-36.65%
EPS Next 2Y4.52%
EPS Next 3Y13.19%
EPS Next 5YN/A
Revenue Next Year-5.48%
Revenue Next 2Y5.99%
Revenue Next 3Y8.18%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
BAKKA.OL Yearly Revenue VS EstimatesBAKKA.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
BAKKA.OL Yearly EPS VS EstimatesBAKKA.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5 10 15 20 25

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 33.46 indicates a quite expensive valuation of BAKKA.
Compared to the rest of the industry, the Price/Earnings ratio of BAKKA indicates a slightly more expensive valuation: BAKKA is more expensive than 66.10% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 25.98. BAKKA is valued slightly more expensive when compared to this.
BAKKA is valuated correctly with a Price/Forward Earnings ratio of 14.38.
BAKKA's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of BAKKA to the average of the S&P500 Index (35.79), we can say BAKKA is valued rather cheaply.
Industry RankSector Rank
PE 33.46
Fwd PE 14.38
BAKKA.OL Price Earnings VS Forward Price EarningsBAKKA.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

BAKKA's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.24
BAKKA.OL Per share dataBAKKA.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150 200 250

4.3 Compensation for Growth

BAKKA's earnings are expected to grow with 13.19% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.52%
EPS Next 3Y13.19%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.92%, BAKKA has a reasonable but not impressive dividend return.
BAKKA's Dividend Yield is a higher than the industry average which is at 3.35.
Compared to an average S&P500 Dividend Yield of 2.41, BAKKA pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.92%

5.2 History

The dividend of BAKKA has a limited annual growth rate of 3.15%.
Dividend Growth(5Y)3.15%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

219.43% of the earnings are spent on dividend by BAKKA. This is not a sustainable payout ratio.
The dividend of BAKKA is growing, but earnings are growing more, so the dividend growth is sustainable.
DP219.43%
EPS Next 2Y4.52%
EPS Next 3Y13.19%
BAKKA.OL Yearly Income VS Free CF VS DividendBAKKA.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B -3B
BAKKA.OL Dividend Payout.BAKKA.OL Dividend Payout, showing the Payout Ratio.BAKKA.OL Dividend Payout.PayoutRetained Earnings

BAKKAFROST P/F

OSL:BAKKA (11/26/2025, 12:42:19 PM)

459.8

+6.2 (+1.37%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)11-04 2025-11-04/bmo
Earnings (Next)02-16 2026-02-16/amc
Inst Owners55.36%
Inst Owner ChangeN/A
Ins Owners16.06%
Ins Owner ChangeN/A
Market Cap27.31B
Revenue(TTM)7.33B
Net Income(TTM)228.10M
Analysts75.56
Price Target551.31 (19.9%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.92%
Yearly Dividend13.73
Dividend Growth(5Y)3.15%
DP219.43%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-60.41%
Min EPS beat(2)-106.11%
Max EPS beat(2)-14.72%
EPS beat(4)0
Avg EPS beat(4)-43.68%
Min EPS beat(4)-106.11%
Max EPS beat(4)-2.8%
EPS beat(8)2
Avg EPS beat(8)-25.32%
EPS beat(12)3
Avg EPS beat(12)-21.81%
EPS beat(16)3
Avg EPS beat(16)-24.75%
Revenue beat(2)0
Avg Revenue beat(2)-17.2%
Min Revenue beat(2)-21.74%
Max Revenue beat(2)-12.67%
Revenue beat(4)0
Avg Revenue beat(4)-16.42%
Min Revenue beat(4)-21.74%
Max Revenue beat(4)-12.34%
Revenue beat(8)1
Avg Revenue beat(8)-10.61%
Revenue beat(12)4
Avg Revenue beat(12)-4.72%
Revenue beat(16)5
Avg Revenue beat(16)-5.03%
PT rev (1m)10.5%
PT rev (3m)-0.26%
EPS NQ rev (1m)-35.69%
EPS NQ rev (3m)-56.85%
EPS NY rev (1m)-10.72%
EPS NY rev (3m)-17.47%
Revenue NQ rev (1m)1.44%
Revenue NQ rev (3m)1.29%
Revenue NY rev (1m)-1.71%
Revenue NY rev (3m)-4.8%
Valuation
Industry RankSector Rank
PE 33.46
Fwd PE 14.38
P/S 2.63
P/FCF N/A
P/OCF 16.73
P/B 1.65
P/tB 2.91
EV/EBITDA 13.24
EPS(TTM)13.74
EY2.99%
EPS(NY)31.97
Fwd EY6.95%
FCF(TTM)-1.7
FCFYN/A
OCF(TTM)27.49
OCFY5.98%
SpS174.53
BVpS278.63
TBVpS158.14
PEG (NY)N/A
PEG (5Y)N/A
Graham Number293.49
Profitability
Industry RankSector Rank
ROA 1.3%
ROE 2.19%
ROCE 5.17%
ROIC 4.1%
ROICexc 4.15%
ROICexgc 5.64%
OM 13.65%
PM (TTM) 3.49%
GM 71.02%
FCFM N/A
ROA(3y)5.68%
ROA(5y)5.43%
ROE(3y)9.21%
ROE(5y)8.65%
ROIC(3y)6.71%
ROIC(5y)5.53%
ROICexc(3y)6.94%
ROICexc(5y)5.73%
ROICexgc(3y)9.65%
ROICexgc(5y)8.22%
ROCE(3y)8.44%
ROCE(5y)6.96%
ROICexgc growth 3Y13.09%
ROICexgc growth 5Y-10.07%
ROICexc growth 3Y16.55%
ROICexc growth 5Y-6.46%
OM growth 3Y13.95%
OM growth 5Y-7.81%
PM growth 3Y-19.8%
PM growth 5Y-13%
GM growth 3Y1.78%
GM growth 5Y0.18%
F-Score5
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF N/A
Debt/EBITDA 2.98
Cap/Depr 145.81%
Cap/Sales 16.72%
Interest Coverage 250
Cash Conversion 62.7%
Profit Quality N/A
Current Ratio 12.9
Quick Ratio 2.27
Altman-Z 2.74
F-Score5
WACC8.07%
ROIC/WACC0.51
Cap/Depr(3y)180.8%
Cap/Depr(5y)188.01%
Cap/Sales(3y)15.4%
Cap/Sales(5y)16.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-50.91%
EPS 3Y21.53%
EPS 5Y-1.36%
EPS Q2Q%-100%
EPS Next Y-36.65%
EPS Next 2Y4.52%
EPS Next 3Y13.19%
EPS Next 5YN/A
Revenue 1Y (TTM)2.7%
Revenue growth 3Y9.71%
Revenue growth 5Y10.21%
Sales Q2Q%-2.9%
Revenue Next Year-5.48%
Revenue Next 2Y5.99%
Revenue Next 3Y8.18%
Revenue Next 5YN/A
EBIT growth 1Y-38.14%
EBIT growth 3Y25.01%
EBIT growth 5Y1.6%
EBIT Next Year23.25%
EBIT Next 3Y28.27%
EBIT Next 5YN/A
FCF growth 1Y-138.63%
FCF growth 3Y431.02%
FCF growth 5YN/A
OCF growth 1Y-29.4%
OCF growth 3Y27.94%
OCF growth 5Y17.84%

BAKKAFROST P/F / BAKKA.OL FAQ

What is the fundamental rating for BAKKA stock?

ChartMill assigns a fundamental rating of 5 / 10 to BAKKA.OL.


What is the valuation status of BAKKAFROST P/F (BAKKA.OL) stock?

ChartMill assigns a valuation rating of 2 / 10 to BAKKAFROST P/F (BAKKA.OL). This can be considered as Overvalued.


How profitable is BAKKAFROST P/F (BAKKA.OL) stock?

BAKKAFROST P/F (BAKKA.OL) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for BAKKA stock?

The Price/Earnings (PE) ratio for BAKKAFROST P/F (BAKKA.OL) is 33.46 and the Price/Book (PB) ratio is 1.65.


Can you provide the dividend sustainability for BAKKA stock?

The dividend rating of BAKKAFROST P/F (BAKKA.OL) is 4 / 10 and the dividend payout ratio is 219.43%.